OverviewSuggest Edit

AbbVie is a pharmaceutical company that discovers, develops, and markets both biopharmaceuticals and small molecule drugs. The company offers Humira, a biologic therapy administered as a subcutaneous injection to treat autoimmune diseases; Imbruvica, an oral therapy for the treatment of patients with chronic lymphocytic leukemia; and Viekira Pak, an interferon-free therapy, with or without ribavirin, for the treatment of adults with genotype 1 chronic hepatitis C.
TypePublic
Founded2013
HQLake Bluff, US
Websiteabbvie.com
Employee Ratings3.9

Latest Updates

Employees (est.) (Jan 2019)30,000(+4%)
Job Openings747
Revenue (FY, 2016)$25.6 B(+13%)
Share Price (Jun 2019)$77

Key People/Management at AbbVie

Richard Gonzalez

Richard Gonzalez

Chairman of the Board and Chief Executive Officer
Carlos Alban

Carlos Alban

Vice Chairman, Chief Commercial Officer
Timothy Richmond

Timothy Richmond

Chief Human Resources Officer, EVP
Azita Saleki-Gerhardt

Azita Saleki-Gerhardt

Executive Vice President, Operations
Laura Schumacher

Laura Schumacher

Executive Vice President, External Affairs, General Counsel and Corporate Secretary
William Chase

William Chase

Executive Vice President, Finance and Administration
Show more

AbbVie Office Locations

AbbVie has offices in Lake Bluff, Sunnyvale, South San Francisco, Cambridge and in 51 other locations
Lake Bluff, US (HQ)
1 Waukegan Rd
Cambridge, US
200 Sidney St
Mettawa, US
26525 Riverwoods Blvd
North Chicago, US
1401 Sheridan Rd
Redwood City, US
1500 Seaport Blvd
South San Francisco, US
450 E Jamie Ct
Show all (60)

AbbVie Financials and Metrics

AbbVie Revenue

Embed Graph
View revenue for all periods
AbbVie's revenue was reported to be $25.64 b in FY, 2016 which is a 12.2% increase from the previous period.
USD

Revenue (Q2, 2019)

8.3b

Gross profit (Q2, 2019)

6.4b

Gross profit margin (Q2, 2019), %

78%

Net income (Q2, 2019)

741.0m

EBIT (Q2, 2019)

3.4b

Market capitalization (10-Jun-2019)

113.8b

Closing stock price (10-Jun-2019)

77.0

Cash (30-Jun-2019)

5.2b

EV

108.9b
AbbVie's current market capitalization is $113.8 b.
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016

Revenue

18.8b20.0b22.9b25.6b

Revenue growth, %

6%15%12%

Cost of goods sold

4.6b4.4b4.5b5.8b

Gross profit

14.2b15.5b18.4b19.8b
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019

Revenue

4.7b4.6b4.9b5.0b5.0b5.5b5.9b6.0b6.5b6.4b6.5b6.9b7.0b7.9b8.3b8.2b7.8b8.3b

Cost of goods sold

1.1b1.1b1.1b1.1b942.0m916.0m1.2b1.4b1.4b1.5b1.6b1.5b1.6b1.9b1.9b1.8b1.7b1.8b

Gross profit

3.6b3.5b3.8b3.9b4.1b4.6b4.8b4.6b5.0b4.9b4.9b5.4b5.4b6.0b6.3b6.4b6.1b6.4b

Gross profit Margin, %

77%76%77%78%81%83%80%77%78%77%75%78%77%76%77%78%78%78%
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016

Cash

9.6b8.3b8.4b5.1b

Accounts Receivable

3.9b3.7b4.7b4.8b

Inventories

1.2b1.1b1.7b1.4b

Current Assets

17.8b16.1b16.3b16.2b
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019

Cash

9.0b8.1b9.1b7.7b7.9b7.4b9.2b7.6b6.3b6.2b4.7b6.1b8.4b9.0b3.5b8.0b4.9b5.2b

Accounts Receivable

3.8b3.7b3.7b3.6b4.2b4.4b4.6b4.8b5.0b5.0b4.7b4.9b4.9b5.8b5.8b5.8b5.7b5.5b

Inventories

1.2b1.1b1.0b1.0b1.0b1.6b1.8b1.8b1.8b1.6b1.4b1.6b1.8b1.7b1.6b1.8b1.7b1.9b

Current Assets

16.5b17.3b17.8b17.6b15.4b16.9b17.9b16.6b16.8b16.3b15.5b17.0b18.9b20.4b13.8b18.5b14.4b15.1b
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

4.1b1.8b5.1b6.0b

Inventories

(56.0m)(203.0m)(434.0m)(38.0m)

Accounts Payable

(426.0m)(193.0m)1.5b(1.2b)

Cash From Operating Activities

6.3b3.5b7.5b7.0b
USDY, 2019

EV/EBIT

29.3 x

Financial Leverage

-6.7 x
Show all financial metrics

AbbVie Acquisitions / Subsidiaries

Acquired CompanyDateDeal Size
AllerganJune 25, 2019$80 b
Stem CentRxApril 28, 2016$5.80 b

AbbVie Online and Social Media Presence

Embed Graph

AbbVie News and Updates

Consumer groups, unions urge caution on $63 bln AbbVie deal for Allergan

About a dozen advocacy groups and unions, including Public Citizen and the American Federation of Teachers, wrote the Federal Trade Commission on Thursday urging it to consider blocking drugmaker AbbVie Inc's planned $63 billion purchase of Botox maker Allergan Plc.

Update: Form 8.3 - AbbVie Inc (Correction of Doc)

                FORM 8.3

AbbVie is shutting down its troubled Rova-T R&D program

Shares of AbbVie Inc. rose 1.5% in premarket trade Thursday after the company announced it had shut down its troubled Rova-T research and development program. The drugmaker said it was discontinuing a late-stage trial of Rova-T as a potential treatment for advanced small-cell lung cancer after inte…

AbbVie terminates late-stage lung cancer trial

AbbVie Inc on Thursday said it will discontinue the late-stage trial testing its experimental treatment for a type of lung cancer after it failed to show a survival benefit compared to placebo.

AbbVie Discontinues Rovalpituzumab Tesirine (Rova-T) Research and Development Program

NORTH CHICAGO, Ill., Aug. 29, 2019 /PRNewswire/ -- AbbVie (NYSE: ABBV), a research based global biopharmaceutical company, today announced that MERU, a Phase 3 trial evaluating Rova-T as a first-line maintenance therapy for advanced small-cell lung cancer (SCLC), demonstrated no survival...

Here are the biggest analyst calls of the day: Beyond Meat, AbbVie, Hewlett Packard & more

Here are the biggest calls on Wall Street on Tuesday.
Show more

AbbVie Frequently Asked Questions

  • When was AbbVie founded?

    AbbVie was founded in 2013.

  • Who are AbbVie key executives?

    AbbVie's key executives are Richard Gonzalez, Carlos Alban and Timothy Richmond.

  • How many employees does AbbVie have?

    AbbVie has 30,000 employees.

  • What is AbbVie revenue?

    Latest AbbVie annual revenue is $25.6 b.

  • What is AbbVie revenue per employee?

    Latest AbbVie revenue per employee is $854.6 k.

  • Who are AbbVie competitors?

    Competitors of AbbVie include Bristol-Myers Squibb, Abbott and Merck.

  • Where is AbbVie headquarters?

    AbbVie headquarters is located at 1 Waukegan Rd, Lake Bluff.

  • Where are AbbVie offices?

    AbbVie has offices in Lake Bluff, Sunnyvale, South San Francisco, Cambridge and in 51 other locations.

  • How many offices does AbbVie have?

    AbbVie has 60 offices.